RxDoctor Payments Data

Jacob Whitney, PA

Physician Assistant · Gilbert, AZNPI 1770119083

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 806 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $5,126 and has fallen 99.7% since, to $14 in 2025. Among physician assistant clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,533in general payments, 2019–2025

Across 806 payments — averaging $15.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$978
  • UCB, Inc.$930
  • Lilly USA, LLC$840
  • Biogen$667
  • Amgen$525
  • plus $6K from 54 others

What the payments were for

  • Speaking & faculty fees$130%
  • Food & beverage$12,507100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)202$2,266
Novartis48$978
UCB, Inc.77$930
Lilly USA, LLC64$840
Biogen37$667
Amgen(2 entities)29$525
CSL Behring17$448
AstraZeneca19$445
Teva Pharmaceuticals USA, Inc.41$445
Pfizer23$407
Kyowa Kirin, Inc.16$325
Biohaven Pharmaceuticals, Inc.18$300
Lundbeck LLC16$290
Eisai Inc.14$287
Argenx US, Inc.13$286
Upsher-smith Laboratories LLC16$240
EMD Serono, Inc.10$211
Neurocrine Biosciences, Inc.10$207
Sanofi9$192
Banner Life Sciences, LLC11$155
Impel Pharmaceuticals Inc.8$154
Avion Pharmaceuticals7$116
Merz Pharmaceuticals, LLC6$115
Genentech USA, Inc.4$103
Acorda Therapeutics, Inc6$93
Neurelis, Inc.6$93
Averitas Pharma Inc.4$93
Amneal Pharmaceuticals LLC6$86
Jazz Pharmaceuticals Inc.4$83
SK Life Science, Inc.4$79
Mallinckrodt Hospital Products Inc.4$78
Sumitomo Pharma America, Inc.6$78
Bristol Myers Squibb4$69
Biohaven Pharmaceutical Holding Company Ltd.3$67
Otsuka America Pharmaceutical, Inc.4$63
MDD US Operations, LLC1$50
Harmony Biosciences LLC2$46
Vanda Pharmaceuticals Inc.3$45
Nevro Corp.3$44
Ipsen Biopharmaceuticals, Inc2$44
Johnson & Johnson2$41
Otto Bock Healthcare LP2$40
ANI Pharmaceuticals, Inc.2$37
TG Therapeutics, Inc.2$37
Idorsia Pharmaceuticals US Inc2$34
Almatica Pharma LLC2$34
Intuitive Surgical1$30
Catalyst Pharmaceuticals, Inc.2$29
Sunovion Pharmaceuticals Inc.2$23
Corium, LLC1$19
GRT US Holding, Inc.1$19
Xeris Pharmaceuticals, Inc.1$18
Currax Pharmaceuticals LLC1$16
GE HealthCare1$16
Alnylam Pharmaceuticals Inc.1$15
Sanofi-aventis U.S. LLC1$14
Supernus Pharmaceuticals, Inc.1$14
Scilex Pharmaceuticals Inc.1$13
Alfasigma USA, Inc.1$13
Arbor Pharmaceuticals, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,533 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$7,897
Medicare patients
76
Services billed
84

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate11$21,059
Gabapentin93$2,205
Levetiracetam20$876
Duloxetine Hcl36$737
Donepezil Hcl51$574
Topiramate46$384
Memantine Hcl23$359
Primidone22$356
Sumatriptan Succinate16$296
Propranolol Hcl ErPropranolol Hcl19$217
Pregabalin18$187
ClopidogrelClopidogrel Bisulfate16$123

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$407$21,05911 claims
Upsher-smith Laboratories LLCTopiramate$240$38446 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Gilbert

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →